Chemical Compound

(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide

CAS Registry Number 25614-03-3
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide 结构式
Primary record

(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide

库存
9,588 克
纯度
98.3 %
CAS
25614-03-3

化合物标识与属性

CAS
25614-03-3
PubChem CID
31101
SMILES
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
Canonical SMILES
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12

名称与同义词

  • bromocriptine
  • Bromocryptine
  • Bromocriptin
  • Bromoergocryptine
  • Bromergocryptine
  • Bromoergocriptine
  • Bromocriptina
  • Bromocriptinum
  • Parlodel
  • Ergoset
  • Bromocryptin
  • Bagren
  • 2-Bromo-alpha-ergocryptine
  • Pravidel
  • 2-Bromoergocryptine
  • 2-Bromo-alpha-ergokryptin
  • ergolactin
  • 2-Bromo-alpha-ergokryptine
  • Bromokryptine
  • Ergocryptine, 2-bromo-
  • Bromergon
  • Apo-Bromocriptine
  • Parlodel Snaptabs
  • 2-Bromoergokryptine
  • Alti-Bromocriptine
  • 25614-03-3
  • (+)-Bromocriptine
  • Bromocriptinum [INN-Latin]
  • Bromocriptina [INN-Spanish]
  • Bromocriptine [BAN]
  • 2-bromoergocriptine
  • Parlodel (TN)
  • 2 Bromoergocryptine
  • 2 Bromoergokryptine
  • BROMOCRITINE
  • BROMOCRIPTINE MESYLATE
  • Bromocriptine mesilate
  • Bromocryptine mesylate
  • Bromocriptine (mesylate)
  • Bromocriptine methanesulfonate
  • CB-154
  • C32H40BrN5O5
  • RefChem:56423
  • Bromocriptine (USAN/INN)
  • Bromocriptine+ (GTP+)
  • Bromocriptine+ (GTP-)
  • AC1L1KXS
  • Prestwick0_000121
  • Prestwick1_000121
  • Prestwick2_000121
  • 3A64E3G5ZO
  • CCRIS 3244
  • UNII-3A64E3G5ZO
  • BROMOCRIPTINE [MI]
  • Bromocriptine [USAN:BAN:INN]
  • DTXSID1022687
  • SANDOZ 15-754
  • 2 Bromo alpha ergocryptine
  • 2 Bromo alpha ergokryptine
  • Biomol-NT_000005
  • CHEMBL493
  • D06YFA
  • GTPL35
  • BROMOCRIPTINE [INN]
  • CHEBI:3181
  • DTXCID602687
  • BROMOCRIPTINE [USAN]
  • Lopac0_000171
  • SCHEMBL25297
  • Bromocriptine [USAN:INN:BAN]
  • BROMOCRIPTINE [VANDF]
  • 2-Bromo-.alpha.-ergocryptine
  • BIDD:GT0464
  • EINECS 247-128-5
  • SPBio_002101
  • BROMOCRIPTINE [WHO-DD]
  • OZVBMTJYIDMWIL-AYFBDAFISA-N
  • BPBio1_001131
  • Ergocryptine, 2-bromo-(8CI)
  • 2-Bromoergocryptine Methanesulfonate
  • SCHEMBL29364057
  • BDBM81993
  • G02CB01
  • N04BC01
  • (+)-Bromocriptine methanesulfonate
  • CB154
  • C32-H40-Br-N5-O5
  • AC1Q2716
  • CID31101
  • Tox21_110907
  • CB 154
  • EBC-27415
  • NSC169774
  • PDSP2_001500
  • ZINC53683151
  • AKOS015961273
  • CCG-204266
  • DB01200
  • SDCCGSBI-0050159.P003
  • NCGC00024584-03
  • NCGC00024584-04
  • NCGC00024584-05
  • NCGC00024584-07
  • NCGC00024584-09
  • NCGC00024584-17
  • NCGC00024584-28
  • AC-13601
  • AC-37665
  • BC206491
  • DA-61890
  • J16.988I
  • LS-64540
  • NCI60_001365
  • CAS-25614-03-3
  • CS-0012283
  • FT-0623234
  • FT-0623235
  • NS00001292
  • C06856
  • D03165
  • 13177-EP2272832A1
  • 13177-EP2275420A1
  • 13177-EP2277876A1
  • 13177-EP2280008A2
  • 13177-EP2287165A2
  • 13177-EP2287166A2
  • 13177-EP2292614A1
  • 13177-EP2292620A2
  • 13177-EP2295412A1
  • 13177-EP2295413A1
  • 13177-EP2295439A1
  • 13177-EP2298731A1
  • 13177-EP2298738A1
  • 13177-EP2298779A1
  • 13177-EP2311808A1
  • 13177-EP2311818A1
  • 13177-EP2311829A1
  • 13177-EP2311837A1
  • 13177-EP2316470A2
  • 13177-EP2316834A1
  • 88085-EP2298415A1
  • 88085-EP2298742A1
  • 88085-EP2305648A1
  • Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
  • EN300-19768234
  • Q413581
  • SR-01000075356
  • SR-01000075356-5
  • (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
  • (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
  • 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
  • BRD-K14496212-001-01-1
  • BRD-K14496212-066-02-2
  • BRD-K14496212-066-04-8
  • 22260-51-1
  • (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
  • (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
  • Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-
  • (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
  • (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
  • Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
  • (5'-a2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3'
  • 2-Bromo-12'-hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
  • SAN 15-754; Sandoz 15-754; -Bromocryptine; -Bromoergocryptine; -Ergolactin
  • (4R,7R)-10-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.0^(2,6))dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
  • (4R,7R)-10-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
  • (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
  • (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
  • (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
  • (5'-alpha)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
  • (5alpha,5'beta)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
  • (6aR,9R)-5-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
  • 08Y
  • 2-Bromo-12 -hydroxy-2 -(1-methylethyl)-5 alpha-(2-methylpropyl)ergotaman-3 ,6 ,18-trione
  • 247-128-5
  • Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1- methylethyl)-5'-(2-methylpropyl)-, (5'?)-
  • Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)-
  • N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide